Trial Profile
Effectiveness of Dolutegravir and Boosted Darunavir Dual Therapy Among Highly Treatment-Experienced Individuals
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Nov 2018
Price :
$35
*
At a glance
- Drugs Darunavir (Primary) ; Dolutegravir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 18 Nov 2018 New trial record
- 07 Oct 2018 Results presented at the IDWeek 2018